GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 156 filers reported holding GERON CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $74,000 | +51.0% | 31,500 | 0.0% | 0.02% | +56.2% |
| Q2 2022 | $49,000 | +14.0% | 31,500 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $43,000 | +13.2% | 31,500 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $38,000 | -11.6% | 31,500 | 0.0% | 0.01% | -21.4% |
| Q3 2021 | $43,000 | -2.3% | 31,500 | 0.0% | 0.01% | -6.7% |
| Q2 2021 | $44,000 | -12.0% | 31,500 | 0.0% | 0.02% | -25.0% |
| Q1 2021 | $50,000 | 0.0% | 31,500 | 0.0% | 0.02% | -16.7% |
| Q4 2020 | $50,000 | -9.1% | 31,500 | 0.0% | 0.02% | -27.3% |
| Q3 2020 | $55,000 | -20.3% | 31,500 | 0.0% | 0.03% | -21.4% |
| Q2 2020 | $69,000 | +86.5% | 31,500 | 0.0% | 0.04% | +55.6% |
| Q1 2020 | $37,000 | -14.0% | 31,500 | 0.0% | 0.03% | +17.4% |
| Q4 2019 | $43,000 | +2.4% | 31,500 | 0.0% | 0.02% | -4.2% |
| Q3 2019 | $42,000 | -10.6% | 31,500 | -6.0% | 0.02% | -11.1% |
| Q2 2019 | $47,000 | +2.2% | 33,500 | +21.8% | 0.03% | -10.0% |
| Q1 2019 | $46,000 | +64.3% | 27,500 | 0.0% | 0.03% | +50.0% |
| Q4 2018 | $28,000 | – | 27,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |